Szyf M, Slack A D
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Endocr Res. 2000 Nov;26(4):921-30. doi: 10.3109/07435800009048618.
We utilized Y1 adrenocortical carcinoma cell line as a model system to dissect the events regulating epigenomic gene silencing in tumor cells. We show here that the chromatin structure of c21 gene is inactive in Y1 cells and that it could be reconfigured to an active form by either expressing antisense mRNA to DNA methyltransferase 1 (dnmt1) or an attenuator of Ras protooncogenic signaling hGAP. Surprisingly however, the known inducer of active chromatin structure the histone deacetylase inhibitor trichostatin A TSA fails to induce expression of c21. These results suggest that the primary cause of c21 gene silencing is independent of histone deacetylation. We present a model to explain the possible roles of the different components of the epigenome and the DNA methylation and demethylation machineries in silencing c21 gene expression.
我们利用Y1肾上腺皮质癌细胞系作为模型系统,来剖析调节肿瘤细胞中表观基因组基因沉默的事件。我们在此表明,c21基因的染色质结构在Y1细胞中是无活性的,并且通过表达DNA甲基转移酶1(dnmt1)的反义mRNA或Ras原癌基因信号传导减弱剂hGAP,它可以重新配置为活性形式。然而,令人惊讶的是,已知的活性染色质结构诱导剂组蛋白脱乙酰酶抑制剂曲古抑菌素A(TSA)未能诱导c21的表达。这些结果表明,c21基因沉默的主要原因与组蛋白去乙酰化无关。我们提出了一个模型,以解释表观基因组的不同成分以及DNA甲基化和去甲基化机制在沉默c21基因表达中的可能作用。